Home

Decisione Seno Alfabeto chads2 vasc anticoagulation corso Ottimismo equilibrio

CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health
CHADS2 and CHA2DS2-VASc score for stroke risk and HAS-BLED score for bleeding risk on oral anticoagulation in atrial fibrillation (AF) - eDucate Health

EMNote.org - EMNote
EMNote.org - EMNote

AnticoagEvaluator App - American College of Cardiology
AnticoagEvaluator App - American College of Cardiology

Anticoagulation highlights from the ESC - The British Journal of Cardiology
Anticoagulation highlights from the ESC - The British Journal of Cardiology

Who will benefit from anticoagulant therapy? Use of the CHADS2 score a | RRCC
Who will benefit from anticoagulant therapy? Use of the CHADS2 score a | RRCC

Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer | JACC: CardioOncology
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer | JACC: CardioOncology

Topic Loops: Anticoagulation - CHA2DS2-VASc calculator - YouTube
Topic Loops: Anticoagulation - CHA2DS2-VASc calculator - YouTube

CHA2DS2-VaSc Score – Primary Care Pharmacy Consortium
CHA2DS2-VaSc Score – Primary Care Pharmacy Consortium

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score | Circulation
Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score | Circulation

Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk

The CHA2DS2-VASc score | Download Table
The CHA2DS2-VASc score | Download Table

Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect
Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect

Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?

JACC Journals - Journals of the American College of Cardiology - ICYMI: Cancer patients with atrial fibrillation and elevated CHA2DS2-VASc score may not be receiving recommended anticoagulation for #stroke prophylaxis. Opportunity to
JACC Journals - Journals of the American College of Cardiology - ICYMI: Cancer patients with atrial fibrillation and elevated CHA2DS2-VASc score may not be receiving recommended anticoagulation for #stroke prophylaxis. Opportunity to

Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions
Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions

JCM | Free Full-Text | Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction
JCM | Free Full-Text | Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction

Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar

Who will benefit from anticoagulant therapy? Use of the CHADS2 score a | RRCC
Who will benefit from anticoagulant therapy? Use of the CHADS2 score a | RRCC

Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study | PLOS ONE
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study | PLOS ONE

EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of

JK Han MD on X: "ESC 2016 AF guidelines: CHADS-VASC & Anticoagulation (no role for ASA!) https://t.co/uYtRtiIiSa #ESCcongress https://t.co/ApEOHJECAU" / X
JK Han MD on X: "ESC 2016 AF guidelines: CHADS-VASC & Anticoagulation (no role for ASA!) https://t.co/uYtRtiIiSa #ESCcongress https://t.co/ApEOHJECAU" / X

Stroke and bleeding risk stratification with the CHADS2-VASc ... | GrepMed
Stroke and bleeding risk stratification with the CHADS2-VASc ... | GrepMed

PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar
PDF] Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score | Semantic Scholar

Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors- Clinical Advisor